Error: Could not add to watchlist. X

Ocata Therapeutics Inc

+ Watchlist
T2N:GR
Ticker Change
T2N:GR has changed to a new ticker symbol
EUR
Volume
0
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-
Market Cap (EUR)
-
Shares Outstanding
-
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Ocata Therapeutics Inc is a biotechnology company that provides medical research services. The Company applies human embryonic stem cell technology in regenerative medicine for retinal and cardiovascular diseases.
ADDRESS
33 Locke Drive
Marlborough, MA 01752
United States
PHONE
1-508-756-1212
  • Paul K Wotton
    President/CEO
  • Edward H Myles "Ted"
    CFO/COO
  • Robert P Lanza
    Chief Scientific Officer
  • Eddy Anglade
    Chief Medical Officer
  • H Le Roux Jooste
    Senior VP:Bus Dev/Chief Commercial Ofcr
Show More